Schambye Hans T.
Chief Executive Officer · 4 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-01-02 | DMRA | Damora Therapeutics, Inc. | Sale | 700 | $21.38 | $14,966.00 | filing |
| 2026-01-02 | DMRA | Damora Therapeutics, Inc. | Option exercise | 1,360 | — | — | filing |
| 2025-07-03 | DMRA | Damora Therapeutics, Inc. | Sale | 735 | $3.38 | $2,484.30 | filing |
| 2025-07-03 | DMRA | Damora Therapeutics, Inc. | Option exercise | 1,360 | — | — | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.